Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Coronavirus | Letter to the Editor

Telehealth for fighting the novel coronavirus: review of activities on Diabetes and Osteoporosis management in outbreak

Authors: Mahnaz Sanjari, Maryam Aalaa, Afshin Ostovar, Ensieh Nasli Esfehani, Bagher Larijani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Excerpt

Today, the Coronavirus (2019-nCoV) pandemic is considered a great threat to the global health, and numerous deaths are attributed to this deadly virus all across the world during the last months. Morbidity and mortality have been reported all across the world during the last two months [1]. As documented in details elsewhere, everybody is susceptible to this newly-emerged coronavirus, but people with underlying conditions such as hypertension and diabetes are more apt to develop serious and life-threatening complications [2]. Although people with osteoporosis and those taking osteoporosis medications are neither at a greater risk for contracting the disease nor more susceptible to develop serious complications, prevention from osteoporotic fractures in the present situation is of utmost importance [3]. However, seeking medical attentions including treatment and monitoring services by osteoporotic patients makes them at a higher risk for the infection. As a matter of fact, in today’s resource-constrained health systems both in developing and developed world, placing extra burden on health systems is quite irresponsible. Moreover patients with osteoporosis and diabetes can exponentially increase their risk of contracting the disease by exposing themselves to hospitals and other healthcare facilities. This can be potentially remedied through promoting usage of digital health technology, and patients with osteoporosis and diabetes should be encouraged to use telehealth services as far as they can, and avoid exposing themselves to the high-risk clinical environments [4]. …
Literature
1.
go back to reference Xu J, Chen Y, Chen H, Cao B. 2019 novel Coronavirus outbreak: a quiz or final exam? Front Med. 2020:1–4. Xu J, Chen Y, Chen H, Cao B. 2019 novel Coronavirus outbreak: a quiz or final exam? Front Med. 2020:1–4.
2.
go back to reference Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020:108118. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020:108118.
3.
go back to reference Foundation IO. COVID-19 and osteoporosis. 2020. Foundation IO. COVID-19 and osteoporosis. 2020.
4.
go back to reference Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). Journal of Telemedicine and Telecare. 2020:1357633 × 20916567. Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). Journal of Telemedicine and Telecare. 2020:1357633 × 20916567.
5.
go back to reference Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Mapping the incidence of the COVID-19 hotspot in Iran–Implications for Travellers. Trav Med Infect Dis. 2020;101630. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Mapping the incidence of the COVID-19 hotspot in Iran–Implications for Travellers. Trav Med Infect Dis. 2020;101630.
6.
go back to reference Bandarian F, Larijani B. World diabetes day: celebrating two decades of progress in combating diabetes and its complications in Iran. J Diabetes Metab Disord. 2019;18(2):743–5. CrossRef Bandarian F, Larijani B. World diabetes day: celebrating two decades of progress in combating diabetes and its complications in Iran. J Diabetes Metab Disord. 2019;18(2):743–5. CrossRef
7.
go back to reference Sanjari M, Aalaa M, Amini MR, Mehrdad N, Adibi H, Esfahani EN, et al. Conceptual map of diabetes education: necessity of establishing iran diabetes academy. J Diabetes Metab Disord. 2019;18(2):729–31. CrossRef Sanjari M, Aalaa M, Amini MR, Mehrdad N, Adibi H, Esfahani EN, et al. Conceptual map of diabetes education: necessity of establishing iran diabetes academy. J Diabetes Metab Disord. 2019;18(2):729–31. CrossRef
Metadata
Title
Telehealth for fighting the novel coronavirus: review of activities on Diabetes and Osteoporosis management in outbreak
Authors
Mahnaz Sanjari
Maryam Aalaa
Afshin Ostovar
Ensieh Nasli Esfehani
Bagher Larijani
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00562-9

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.